MedTrace Logo

Smoking Cessation: Financial Incentives

NCT03849092 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1934

Last updated 2020-08-26

No results posted yet for this study

Summary

The aim of this intervention is to test if the investigator, by offering a financial incentive to smokers who abstinence from smoking, can:

1. recruit more smokers with low socioeconomic status to municipal smoking cessation programs
2. achieve higher abstinence rates at municipal smoking cessation programs among citizens with low economic status - Rather than by use of campaigns (=usual strategy) informing citizens about their options for support at municipal smoking cessation programs?

Conditions

  • Smoking Cessation

Interventions

BEHAVIORAL

Financial incentives

Cessation programs in municipalities will offer a financial incentive of 1200 DKK to smokers who achieve continuous abstinence from smoking when attending a group-based smoking cessation program. Aimed at smokers with low socioeconomic status but other smokers are also included.

BEHAVIORAL

Campaigns

Municipalities will design anti-smoking campaigns targeting smokers, recommending to use a municipal free group-based smoking cessation program. Aimed at smokers with low socioeconomic status but other smokers are also included.

Sponsors & Collaborators

  • Glostrup University Hospital, Copenhagen

    lead OTHER

Principal Investigators

  • Charlotta Pisinger, Professor, MD, PhD, MPH · Centre for Clinical Research and Prevention

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-12-31
Completion
2020-07-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03849092 on ClinicalTrials.gov